These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30716504)

  • 1. Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies.
    Dotta L; Notarangelo LD; Moratto D; Kumar R; Porta F; Soresina A; Lougaris V; Plebani A; Smith CIE; Norlin AC; Gòmez Raccio AC; Bubanska E; Bertolini P; Amendola G; Visentini M; Fiorilli M; Venuti A; Badolato R
    J Allergy Clin Immunol Pract; 2019; 7(5):1568-1577. PubMed ID: 30716504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome.
    Dotta L; Tassone L; Badolato R
    Curr Mol Med; 2011 Jun; 11(4):317-25. PubMed ID: 21506920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry.
    Beaussant Cohen S; Fenneteau O; Plouvier E; Rohrlich PS; Daltroff G; Plantier I; Dupuy A; Kerob D; Beaupain B; Bordigoni P; Fouyssac F; Delezoide AL; Devouassoux G; Nicolas JF; Bensaid P; Bertrand Y; Balabanian K; Chantelot CB; Bachelerie F; Donadieu J
    Orphanet J Rare Dis; 2012 Sep; 7():71. PubMed ID: 23009155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients.
    Geier CB; Ellison M; Cruz R; Pawar S; Leiss-Piller A; Zmajkovicova K; McNulty SM; Yilmaz M; Evans MO; Gordon S; Ujhazi B; Wiest I; Abolhassani H; Aghamohammadi A; Barmettler S; Bhar S; Bondarenko A; Bolyard AA; Buchbinder D; Cada M; Cavieres M; Connelly JA; Dale DC; Deordieva E; Dorsey MJ; Drysdale SB; Ehl S; Elfeky R; Fioredda F; Firkin F; Förster-Waldl E; Geng B; Goda V; Gonzalez-Granado L; Grunebaum E; Grzesk E; Henrickson SE; Hilfanova A; Hiwatari M; Imai C; Ip W; Jyonouchi S; Kanegane H; Kawahara Y; Khojah AM; Kim VH; Kojić M; Kołtan S; Krivan G; Langguth D; Lau YL; Leung D; Miano M; Mersyanova I; Mousallem T; Muskat M; Naoum FA; Noronha SA; Ouederni M; Ozono S; Richmond GW; Sakovich I; Salzer U; Schuetz C; Seeborg FO; Sharapova SO; Sockel K; Volokha A; von Bonin M; Warnatz K; Wegehaupt O; Weinberg GA; Wong KJ; Worth A; Yu H; Zharankova Y; Zhao X; Devlin L; Badarau A; Csomos K; Keszei M; Pereira J; Taveras AG; Beaussant-Cohen SL; Ong MS; Shcherbina A; Walter JE
    J Clin Immunol; 2022 Nov; 42(8):1748-1765. PubMed ID: 35947323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndrome.
    Dale DC; Dick E; Kelley M; Makaryan V; Connelly J; Bolyard AA
    Curr Opin Hematol; 2020 Jan; 27(1):11-17. PubMed ID: 31652152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome.
    Badolato R; Donadieu J;
    Blood; 2017 Dec; 130(23):2491-2498. PubMed ID: 29066537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebellar involvement in warts Hypogammaglobulinemia immunodeficiency myelokathexis patients: neuroimaging and clinical findings.
    Galli J; Pinelli L; Micheletti S; Palumbo G; Notarangelo LD; Lougaris V; Dotta L; Fazzi E; Badolato R
    Orphanet J Rare Dis; 2019 Feb; 14(1):61. PubMed ID: 30819232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.
    McDermott DH; Velez D; Cho E; Cowen EW; DiGiovanna JJ; Pastrana DV; Buck CB; Calvo KR; Gardner PJ; Rosenzweig SD; Stratton P; Merideth MA; Kim HJ; Brewer C; Katz JD; Kuhns DB; Malech HL; Follmann D; Fay MP; Murphy PM
    J Clin Invest; 2023 Oct; 133(19):. PubMed ID: 37561579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetralogy of fallot is an uncommon manifestation of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome.
    Badolato R; Dotta L; Tassone L; Amendola G; Porta F; Locatelli F; Notarangelo LD; Bertrand Y; Bachelerie F; Donadieu J
    J Pediatr; 2012 Oct; 161(4):763-5. PubMed ID: 22748845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.
    McDermott DH; Liu Q; Ulrick J; Kwatemaa N; Anaya-O'Brien S; Penzak SR; Filho JO; Priel DA; Kelly C; Garofalo M; Littel P; Marquesen MM; Hilligoss D; Decastro R; Fleisher TA; Kuhns DB; Malech HL; Murphy PM
    Blood; 2011 Nov; 118(18):4957-62. PubMed ID: 21890643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Hematologic Effects of Endotoxin in Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome Model Mice.
    Majumdar S; Gao JL; Pontejo SM; Balabanian K; Bachelerie F; Murphy PM
    Immunohorizons; 2022 Jul; 6(7):543-558. PubMed ID: 35882421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
    Laberko A; Deordieva E; Krivan G; Goda V; Bhar S; Kawahara Y; Rao K; Worth A; McDermott DH; Balashov D; Maschan A; Shcherbina A
    J Clin Immunol; 2022 Jan; 42(1):171-182. PubMed ID: 34697698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Late diagnosis of WHIM sydrome].
    Paolini MV; Danielian S; Prieto E; Tami MF; Oleastro MM; Fernández Romero DS
    Medicina (B Aires); 2018; 78(2):123-126. PubMed ID: 29659363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive Immunodeficiency in WHIM Syndrome.
    Majumdar S; Murphy PM
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plerixafor on a WHIM - Promise or Fantasy of a New CXCR4 Inhibitor for This Rare, but Important Syndrome?
    Merati N; Sivachandran S; Jfri A; Ben-Shoshan M; Vinh DC; Popradi G; Litvinov IV
    Skin Therapy Lett; 2022 Mar; 27(2):1-5. PubMed ID: 35385630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure.
    Heusinkveld LE; Majumdar S; Gao JL; McDermott DH; Murphy PM
    J Clin Immunol; 2019 Aug; 39(6):532-556. PubMed ID: 31313072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome.
    Siedlar M; Rudzki Z; Strach M; Trzyna E; Pituch-Noworolska A; Błaut-Szlósarczyk A; Bukowska-Strakova K; Lenart M; Grodzicki T; Zembala M
    Arch Immunol Ther Exp (Warsz); 2008; 56(6):419-25. PubMed ID: 19043667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-level Cxcr4-haploinsufficient HSC engraftment is sufficient to correct leukopenia in WHIM syndrome mice.
    Gao JL; Owusu-Ansah A; Paun A; Beacht K; Yim E; Siwicki M; Yang A; Liu Q; McDermott DH; Murphy PM
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31687976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHIM syndrome: congenital immune deficiency disease.
    Kawai T; Malech HL
    Curr Opin Hematol; 2009 Jan; 16(1):20-6. PubMed ID: 19057201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [WHIM syndrome: presumptive diagnosis based on myelokathexis on bone marrow smear].
    Bock I; Dugué F; Loppinet E; Bellanné-Chantelot C; Bénet B
    Ann Biol Clin (Paris); 2014; 72(1):111-9. PubMed ID: 24492099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.